All prices include GST and are in NZ dollars
Emergency Contraceptive Pill Accreditation Training - On Demand
Accreditation Course On Demand Women's Health
INTERNS PLEASE NOTE: You will only be able to register and undertake the training courses after you have been issued a full Annual Practicing Certificate (in the pharmacist scope) from the Pharmacy Council of New Zealand and informed PSNZ of this.
Endometriosis - On Demand
On Demand Women's Health
Join this training course to learn about Endometriosis. Our presenter will provide a brief overview of endometriosis, covering its aetiology, and the what, why and where of this enigmatic disease. We will discuss early intervention for dysmenorrhoea and why it matters. Best practice treatments and management with a multi-disciplinary approach will be presented and discussed. We will take time to review a few relevant case studies.
Eye On Demand
Community pharmacies have a great opportunity to help people maintain good eye health. Pharmacists are often consulted for over-the-counter medications to relief many different minor eye ailments, such as dry eye, conjunctivitis, and eyelid diseases. This webinar offers an optometrist’s clinical insight to the therapeutic management of these common eye conditions to support pharmacists in providing enhanced patient eye care and advice.
Heart Health Series - Hypertension
Cardiovascular System On Demand
In New Zealand the prevalence of hypertension is increasing to the point where nearly 25% of NZ adults live with hypertension (2020/21). Despite the known cardiovascular complications caused by hypertension, almost half of all people with hypertension do not have their blood pressure controlled.
New evidence-based guidelines recommend new thresholds and targets for the diagnosis and treatment of hypertension.
This module covers the incidence of hypertension in NZ, the risk factor both for and from hypertension, especially if it is not well controlled, the importance of managing lifestyle factors as part of treatment and the recommended guidelines for pharmacological therapy for hypertension.